Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.21.2
Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income
Total New Residential Stockholders’ Equity
Noncontrolling Interests in Equity of Consolidated Subsidiaries
Preferred Stock
Preferred Stock
Preferred Stock
Preferred Stock
Total New Residential Stockholders’ Equity
Common Stock
Common Stock
Common Stock
Common Stock
Additional Paid-in Capital
Common Stock
Total New Residential Stockholders’ Equity
Cumulative Effect, Adjustment
Cumulative Effect, Adjustment
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Adjustment
Total New Residential Stockholders’ Equity
Cumulative Effect, Adjustment
Noncontrolling Interests in Equity of Consolidated Subsidiaries
Equity, beginning balance (in shares) at Dec. 31, 2019   17,510,000 415,520,780                                
Equity, beginning balance at Dec. 31, 2019 $ 7,236,260 $ 423,444 $ 4,156 $ 5,498,226 $ 549,733 $ 682,151 $ 7,157,710 $ 78,550               $ 30,453 $ 13,658 $ 13,658 $ 16,795
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
2020 Warrants 53,462     53,462     53,462                        
Dividends declared on common stock (124,718)       (124,718)   (124,718)                        
Dividends declared on preferred stock (39,938)       (39,938)   (39,938)                        
Capital contributions 1,818             1,818                      
Capital distributions (31,844)             (31,844)                      
Issuance of stock (in shares)                   16,100,000     97,394            
Issuance of common stock                 $ 389,548 $ 389,548 $ 389,548 $ 1,662 $ 1 $ 1,661 $ 1,662        
Director share grants (in shares)     126,344                                
Director share grants 1,211   $ 1 1,210     1,211                        
Comprehensive income (loss)                                      
Net income (loss) (1,459,206)       (1,493,324)   (1,493,324) 34,118                      
Unrealized gain (loss) on available-for-sale securities, net 108,308         108,308 108,308                        
Reclassification of realized (gain) loss on available-for-sale securities, net into net income (738,385)         (738,385) (738,385)                        
Comprehensive income (loss) (2,089,283)           (2,123,401) 34,118                      
Equity, ending balance (in shares) at Sep. 30, 2020   33,610,000 415,744,518                                
Equity, ending balance at Sep. 30, 2020 5,428,631 $ 812,992 $ 4,158 5,554,559 (1,094,589) 52,074 5,329,194 99,437                      
Equity, beginning balance (in shares) at Jun. 30, 2020   33,610,000 415,744,518                                
Equity, beginning balance at Jun. 30, 2020 5,388,972 $ 812,992 $ 4,158 5,554,559 (1,110,148) 30,730 5,292,291 96,681                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Dividends declared on common stock (62,362)       (62,362)   (62,362)                        
Dividends declared on preferred stock (14,359)       (14,359)   (14,359)                        
Capital contributions 25             25                      
Capital distributions (8,909)             (8,909)                      
Comprehensive income (loss)                                      
Net income (loss) 103,920       92,280   92,280 11,640                      
Unrealized gain (loss) on available-for-sale securities, net 17,535         17,535 17,535                        
Reclassification of realized (gain) loss on available-for-sale securities, net into net income 3,809         3,809 3,809                        
Comprehensive income (loss) 125,264           113,624 11,640                      
Equity, ending balance (in shares) at Sep. 30, 2020   33,610,000 415,744,518                                
Equity, ending balance at Sep. 30, 2020 5,428,631 $ 812,992 $ 4,158 5,554,559 (1,094,589) 52,074 5,329,194 99,437                      
Equity, beginning balance (in shares) at Dec. 31, 2020   33,610,000 414,744,518                                
Equity, beginning balance at Dec. 31, 2020 5,429,684 $ 812,992 $ 4,148 5,547,108 (1,108,929) 65,697 5,321,016 108,668                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Dividends declared on common stock (292,920)       (292,920)   (292,920)                        
Dividends declared on preferred stock (44,249)       (44,249)   (44,249)                        
Capital distributions (45,017)             (45,017)                      
Issuance of stock (in shares)                   18,600,000     51,725,000            
Issuance of common stock                 449,506 $ 449,506 449,506 $ 511,487 $ 517 $ 510,970 $ 511,487        
Purchase of noncontrolling interests (22,523)     (1,447)     (1,447) (21,076)                      
Director share grants (in shares)     110,402                                
Director share grants 1,110     1,108     1,110           $ 2            
Comprehensive income (loss)                                      
Net income (loss) 617,743       589,295   589,295 28,448                      
Unrealized gain (loss) on available-for-sale securities, net 27,680         27,680 27,680                        
Reclassification of realized (gain) loss on available-for-sale securities, net into net income (5,388)         (5,388) (5,388)                        
Comprehensive income (loss) 640,035           611,587 28,448                      
Equity, ending balance (in shares) at Sep. 30, 2021   52,210,000 466,579,920                                
Equity, ending balance at Sep. 30, 2021 6,627,113 $ 1,262,498 $ 4,667 6,057,739 (856,803) 87,989 6,556,090 71,023                      
Equity, beginning balance (in shares) at Jun. 30, 2021   33,610,000 466,579,920                                
Equity, beginning balance at Jun. 30, 2021 6,166,151 $ 812,992 $ 4,667 6,059,186 (886,305) 81,511 6,072,051 94,100                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Dividends declared on common stock (116,645)       (116,645)   (116,645)                        
Dividends declared on preferred stock (15,533)       (15,533)   (15,533)                        
Capital distributions (11,002)             (11,002)                      
Issuance of stock (in shares)                   18,600,000                  
Issuance of common stock                 $ 449,506 $ 449,506 $ 449,506                
Purchase of noncontrolling interests (22,523)     (1,447)     (1,447) (21,076)                      
Comprehensive income (loss)                                      
Net income (loss) 170,681       161,680   161,680 9,001                      
Unrealized gain (loss) on available-for-sale securities, net 6,541         6,541 6,541                        
Reclassification of realized (gain) loss on available-for-sale securities, net into net income (63)         (63) (63)                        
Comprehensive income (loss) 177,159           168,158 9,001                      
Equity, ending balance (in shares) at Sep. 30, 2021   52,210,000 466,579,920                                
Equity, ending balance at Sep. 30, 2021 $ 6,627,113 $ 1,262,498 $ 4,667 $ 6,057,739 $ (856,803) $ 87,989 $ 6,556,090 $ 71,023